148 related articles for article (PubMed ID: 34542014)
21. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey.
Hasegawa K; Kokudo N; Makuuchi M; Izumi N; Ichida T; Kudo M; Ku Y; Sakamoto M; Nakashima O; Matsui O; Matsuyama Y
J Hepatol; 2013 Apr; 58(4):724-9. PubMed ID: 23178708
[TBL] [Abstract][Full Text] [Related]
22. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation.
Jiang T; Zhang X; Ding J; Duan B; Lu S
Int J Clin Exp Pathol; 2015; 8(11):13945-56. PubMed ID: 26823706
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of percutaneous ethanol injection versus radiofrequency ablation for single hepatocellular carcinoma no larger than 5 cm.
Yang P; Li N
J Int Med Res; 2022 Jul; 50(7):3000605221111281. PubMed ID: 35861264
[TBL] [Abstract][Full Text] [Related]
24. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.
Shen A; Zhang H; Tang C; Chen Y; Wang Y; Zhang C; Wu Z
J Gastroenterol Hepatol; 2013 May; 28(5):793-800. PubMed ID: 23432154
[TBL] [Abstract][Full Text] [Related]
25. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
Xu C; Lv PH; Huang XE; Wang SX; Sun L; Wang FA
Asian Pac J Cancer Prev; 2016; 17(9):4349-4352. PubMed ID: 27797242
[TBL] [Abstract][Full Text] [Related]
26. [The validity of radiofrequency ablation for hepatocellular carcinoma].
Yokoyama Y; Yamasaki T; Kurokawa F; Okita K
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2105-9. PubMed ID: 15628752
[TBL] [Abstract][Full Text] [Related]
27. Combined therapy of radiofrequency ablation and ethanol injection of rabbit liver: an in vivo feasibility study.
Lee JM; Lee YH; Kim YK; Kim SW; Kim CS
Cardiovasc Intervent Radiol; 2004; 27(2):151-7. PubMed ID: 15259811
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma.
Bouza C; López-Cuadrado T; Alcázar R; Saz-Parkinson Z; Amate JM
BMC Gastroenterol; 2009 May; 9():31. PubMed ID: 19432967
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial.
Brunello F; Veltri A; Carucci P; Pagano E; Ciccone G; Moretto P; Sacchetto P; Gandini G; Rizzetto M
Scand J Gastroenterol; 2008; 43(6):727-35. PubMed ID: 18569991
[TBL] [Abstract][Full Text] [Related]
31. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis.
Luo W; Zhang Y; He G; Yu M; Zheng M; Liu L; Zhou X
World J Surg Oncol; 2017 Jul; 15(1):126. PubMed ID: 28693505
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma.
Luo BM; Wen YL; Yang HY; Zhi H; Xiao XY; Ou B; Pan JS; Ma JH
World J Gastroenterol; 2005 Oct; 11(40):6277-80. PubMed ID: 16419155
[TBL] [Abstract][Full Text] [Related]
33. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
[TBL] [Abstract][Full Text] [Related]
34. Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection.
Wakui N; Iida K; Ikehara T; Takayama R; Shiozawa K; Takahashi M; Nagai H; Watanabe M; Ishii K; Igarashi Y; Sumino Y
Hepatogastroenterology; 2010; 57(98):195-201. PubMed ID: 20583411
[TBL] [Abstract][Full Text] [Related]
35. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
[TBL] [Abstract][Full Text] [Related]
36. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection.
Oeda S; Mizuta T; Isoda H; Kuwashiro T; Iwane S; Takahashi H; Kawaguchi Y; Eguchi Y; Ozaki I; Tanaka K; Fujimoto K
Hepatogastroenterology; 2013 Sep; 60(126):1399-404. PubMed ID: 23635508
[TBL] [Abstract][Full Text] [Related]
37. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
38. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice].
Romero Gutiérrez M; Ruano Díaz L; Muñoz López D; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; de la Cruz Pérez G; Gómez Rodríguez R
Gastroenterol Hepatol; 2015 Feb; 38(2):54-61. PubMed ID: 25499846
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis.
Dong W; Zhang T; Wang ZG; Liu H
World J Gastroenterol; 2014 Aug; 20(29):10174-82. PubMed ID: 25110446
[TBL] [Abstract][Full Text] [Related]
40. [Radiofrequency ablation combined with ethanol injection for liver cancer treatment---an experimental study].
Zhang YJ; Chen MS; Li JQ; Zhang YQ; Zhong C; Liang HH
Ai Zheng; 2006 Sep; 25(9):1092-6. PubMed ID: 16965648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
